A favourable political and financial environment, a talent pool, a cutting-edge research infrastructure and a geographic location that opens onto North America and Europe: Montréal offers the best conditions for success for companies in the life sciences and health technologies (LSHT) sector.
Montréal’s LSHT ecosystem has developed into a concentration of strong niches of excellence in which scientific and industrial partnerships broaden. The quick emergence of health technologies, personalized medicine and genomics also acts as a vehicle for innovation for industries. The Montréal metropolitan area is a talent incubator that brings together a critical mass of entrepreneurs, researchers and investors, who give rise and generate the treatments and medicine technologies of tomorrow.
The pharmacoeconomist intervenes in the development cycle of new products at the market access stage. He or she conducts economic evaluations and budget impact analyses. He or she compares, for example, the cost-effectiveness ratio of a new drug with existing treatments and may make the connection with the impacts for the systems in place.
The bioinformatician creates, develops and enhances programs and software that allow biological data to be stored, classified and analyzed. It builds a bridge between biology, which is necessary for interpreting biological data and the computer-based methods needed to process and analyze this data.
Health-focused artificial intelligence (AI) specialist
The health-focused artificial intelligence (AI) specialist programs models/algorithms that accomplish tasks usually carried out by human being to process and analyze collected data. The AI specialist makes sure that the model is executable and deployable on a large scale in specific environments.
Medical sciences liaison officer
The medical sciences liaison officer must establish and maintain relations with the experts or the opinion leaders of a specific medical sector and the key community stakeholders in order to present them with evidence and clinical studies on new products, therapies, procedures and technologies.